Stocks · Health care · Surgical & Medical Instruments & Apparatus

Pulmonx Corp

LUNG Clue Score49
United States Fiscal year ends December CIK 0001127537 Results filed 27 Oct 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
39.9×

Glendon E. French holds 39.9 times base salary in stock. $4.65M of shares against $116.19K in salary for 2025.

Salary from the company's own proxy. The shares are what Glendon E. French last reported holding, valued at $2.26, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Glendon E. French III
President and CEO
—
—
—
2,056,134
$4.65M
+88.0%
Derrick Sung
COO and CFO
—
—
—
1,335,319
$3.02M
+886.8%
Geoffrey Beran Rose
Chief Commercial Officer
—
—
—
449,832
$1.02M
+52.3%
David Aaron Lehman
General Counsel
—
—
—
361,827
$817.73K
+77.9%
Steven S. Williamson
President and CEO
—
—
—
358,967
$811.27K
+59.9%
Srikanth Radhakrishnan
Chief Science & Techn. Officer
—
—
—
316,994
$716.41K
+74.9%
Mehul Joshi
Chief Financial Officer & PAO
—
—
—
208,489
$471.19K
+59.3%
Georgia Melenikiotou
Director
—
—
—
139,714
$315.75K
+123.3%
Dana G Mead Jr.
Director
—
—
—
139,714
$315.75K
+123.3%
Daniel P Florin
Director
—
—
—
133,910
$302.64K
+135.9%
Richard Ferrari
Director
—
—
—
127,024
$287.07K
+119.5%
Tiffany Sullivan
Director
—
—
—
115,199
$260.35K
+202.8%
Thomas William Burns
Director
—
—
—
113,399
$256.28K
+212.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.